CRP and myeloid sarcoma: This vulnerability extends to neuroinflammatory disorders, where antecedent vaccinations or systemic infections alter cerebrospinal fluid (CSF) and serum profiles of inflammatory mediators, including CRP and leukocyte subpopulations, critically undermining diagnostic specificity in paediatric MS (pMS) (23).